Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
Sponsor: Virginia Commonwealth University
Summary
Nonalcoholic Steatohepatitis (NASH) is a condition with increased amount of fat, inflammation and scarring in the liver. In compensated cirrhosis, the liver is coping with this damage and maintaining its important functions. Decompensation occurs when the liver becomes unable to perform all of its functions adequately. Variceal hemorrhage (bleeding from abnormal vessels in the liver called varices), Ascites (abnormal build-up of fluid in the abdomen), and Encephalopathy (brain confusion as a result of the liver not being able to get rid of toxic substances) are three symptoms of liver decompensation. The purpose of this research study is to investigate better ways to routinely monitor the condition of patients with NASH with compensated cirrhosis and to better pinpoint the development of decompensation in the livers of these patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
240
Start Date
2023-04-19
Completion Date
2027-12
Last Updated
2026-04-02
Healthy Volunteers
No
Conditions
Interventions
Standard of care
Participants will receive the standard of care for their condition
Locations (2)
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Virginia Commonwealth University
Richmond, Virginia, United States